Molecular epidemiology of infectious diseases: the example of meningococcal disease

Research in Microbiology

Volumn 159, Issue 1, 2008, Pages 62-66

  Taha, Muhamed Kheir ^a   Alonso, Jean Michel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; DIAGNOSTIC PROCEDURE; HUMAN; INFECTION; INFECTION CONTROL; LETTER; MENINGOCOCCOSIS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NEISSERIA MENINGITIDIS; PHENOTYPE; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT; VIRULENCE;

EPIDEMIOLOGY, MOLECULAR; HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS;

EID: 39149121806     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2007.11.017     Document Type: Letter

References (37)

1. Abdillahi H., and Poolman J.T. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies. FEMS Microbiol. Immunol. 1 (1988) 139-144
2. Boisier P., Nicolas P., Djibo S., Taha M.K., Jeanne I., Mainassara H.B., Tenebray B., Kairo K.K., Giorgini D., and Chanteau S. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin. Infect. Dis. 44 (2007) 657-663
3. Borrow R., Claus H., Guiver M., Smart L., Jones D.M., Kaczmarski E.B., Frosch M., and Fox A.J. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol. Infect. 118 (1997) 111-117
4. Caugant D.A. Population genetics and molecular epidemiology of Neisseria meningitidis. Apmis 106 (1998) 505-525
5. Feil E.J., Holmes E.C., Bessen D.E., Chan M.S., Day N.P., Enright M.C., Goldstein R., Hood D.W., Kalia A., Moore C.E., Zhou J., and Spratt B.G. Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 182-187
6. Fox A.J., Taha M.K., and Vogel U. Standardized nonculture techniques recommended for European reference laboratories. FEMS Microbiol. Rev. 31 (2007) 84-88
7. Galimand M., Gerbaud G., Guibourdenche M., Riou J.Y., and Courvalin P. High-level chloramphenicol resistance in Neisseria meningitidis. N. Engl. J. Med. 339 (1998) 868-874
8. Guibourdenche M., and Riou J.Y. Méthodes de laboratoire: Neisseria et Branhamella. Commission des Laboratoires de Référence et d'Expertise (1992), Institut Pasteur, Paris
9. Harmsen D., Singer C., Rothganger J., Tonjum T., de Hoog G.S., Shah H., Albert J., and Frosch M. Diagnostics of neisseriaceae and moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J. Clin. Microbiol. 39 (2001) 936-942
10. Issa M., Molling P., Unemo M., Backman A., Mosaad M., Sulaiman N., and Olcen P. Neisseria meningitidis serogroup W-135 isolated from healthy carriers and patients in Sudan after the Hajj in 2000. Scand. J. Infect. Dis. 35 (2003) 230-233
11. Kertesz D.A., Coulthart M.B., Ryan J.A., Johnson W.M., and Ashton F.E. Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada. J. Infect. Dis. 177 (1998) 1754-1757
12. Kriz P., Giorgini D., Musilek M., Larribe M., and Taha M.K. Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic. Res. Microbiol. 150 (1999) 273-280
13. Kriz P., Kalmusova J., and Felsberg J. Multilocus sequence typing of Neisseria meningitidis directly from cerebrospinal fluid. Epidemiol. Infect. 128 (2002) 157-160
14. Lancellotti M., Guiyoule A., Ruckly C., Hong E., Alonso J.M., and Taha M.K. Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex. Microbes Infect 8 (2006) 191-196
15. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6571-6576
16. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., Zhang Q., Zhou J., Zurth K., Caugant D.A., Feavers I.M., Achtman M., and Spratt B.G. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3140-3145
17. Mayer L.W., Reeves M.W., Al-Hamdan N., Sacchi C.T., Taha M.K., Ajello G.W., Schmink S.E., Noble C.A., Tondella M.L., Whitney A.M., Al-Mazrou Y., Al-Jefri M., Mishkhis A., Sabban S., Caugant D.A., Lingappa J., Rosenstein N.E., and Popovic T. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J. Infect. Dis. 185 (2002) 1596-1605
18. Molling P., Backman A., Olcen P., and Fredlund H. Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage. J. Clin. Microbiol. 39 (2001) 2695-2699
19. Ninet B., Bannerman E., and Bille J. Assessment of the Accuprobe Listeria monocytogenes culture identification reagent kit for rapid colony confirmation and its application in various enrichment broths. Appl. Environ. Microbiol. 58 (1992) 4055-4059
20. Popovic T., Schmink S., Rosenstein N.A., Ajello G.W., Reeves M.W., Plikaytis B., Hunter S.B., Ribot E.M., Boxrud D., Tondella M.L., Kim C., Noble C., Mothershed E., Besser J., and Perkins B.A. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J. Clin. Microbiol. 39 (2001) 75-85
21. Shultz T.R., Tapsall J.W., White P.A., and Newton P.J. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrob. Agents Chemother 44 (2000) 1116
22. Shultz T.R., Tapsall J.W., White P.A., Ryan C.S., Lyras D., Rood J.I., Binotto E., and Richardson C.J. Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia. J. Antimicrob. Chemother 52 (2003) 856-859
23. Spratt B.G. Resistance to antibiotics mediated by target alterations. Science 264 (1994) 388-393
24. Spratt B.G., and Maiden M.C. Bacterial population genetics, evolution and epidemiology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354 (1999) 701-710
25. Swartley J.S., Marfin A.A., Edupuganti S., Liu L.J., Cieslak P., Perkins B., Wenger J.D., and Stephens D.S. Capsule switching of Neisseria meningitidis. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 271-276
26. Taha M.K. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J. Clin. Microbiol. 38 (2000) 855-857
27. Taha M.K., Achtman M., Alonso J.M., Greenwood B., Ramsay M., Fox A., Gray S., and Kaczmarski E. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356 (2000) 2159
28. Taha M.K., Alonso J.M., Cafferkey M., Caugant D.A., Clarke S.C., Diggle M.A., Fox A., Frosch M., Gray S.J., Guiver M., Heuberger S., Kalmusova J., Kesanopoulos K., Klem A.M., Kriz P., Marsh J., Mölling P., Murphy K., Olcén P., Sanou O., Tzanakaki G., and Vogel U. Interlaboratory Comparison of PCR-Based Identification and Genogrouping of Neisseria meningitidis. J. Clin. Microbiol. 43 (2005) 144-149
29. Taha M.K., Giorgini D., Ducos-Galand M., and Alonso J.M. The continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease, after its emergence in 2000. J. Clin. Microbiol. 42 (2004) 4158-4163
30. Taha M.K., Parent Du Chatelet I., Schlumberger M., Sanou I., Djibo S., de Chabalier F., and Alonso J.M. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J. Clin. Microbiol. 40 (2002) 1083-1084
31. Taha M.K., Vazquez J.A., Hong E., Bennett D.E., Bertrand S., Bukovski S., Cafferkey M.T., Carion F., Christensen J.J., Diggle M., Edwards G., Enriquez R., Fazio C., Frosch M., Heuberger S., Hoffmann S., Jolley K.A., Kadlubowski M., Kechrid A., Kesanopoulos K., Kriz P., Lambertsen L., Levenet I., Musilek M., Paragi M., Saguer A., Skoczynska A., Stefanelli P., Thulin S., Tzanakaki G., Unemo M., Vogel U., and Zarantonelli M.L. Target gene sequencing to characterize penicillin G susceptibility of Neisseria meningitidis. Antimicrob. Agents Chemother 51 (2007) 2784-2792
32. Taha M.K., Zarantonelli M.L., Ruckly C., Giorgini D., and Alonso J.M. Rifampin-resistant Neisseria meningitidis. Emerg. Infect. Dis. 12 (2006) 859-860
33. Tenover F.C. DNA hybridization techniques and their application to the diagnosis of infectious diseases. Infect. Dis. Clin. North Am. 7 (1993) 171-181
34. Tondella M.L., Rosenstein N.E., Mayer L.W., Tenover F.C., Stocker S.A., Reeves M.W., and Popovic T. Lack of evidence for chloramphenicol resistance in Neisseria meningitidis, Africa. Emerg. Infect. Dis. 7 (2001) 163-164
35. Tsai C.M., Mocca L.F., and Frasch C.E. Immunotype epitopes of Neisseria meningitidis lipooligosaccharide types 1 through 8. Infect. Immun. 55 (1987) 1652-1656
36. Tzeng Y.L., Noble C., and Stephens D.S. Genetic basis for biosynthesis of the (alpha 1→4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X. Infect. Immun. 71 (2003) 6712-6720
37. Vazquez J.A., Arreaza L., Block C., Ehrhard I., Gray S.J., Heuberger S., Hoffmann S., Kriz P., Nicolas P., Olcen P., Skoczynska A., Spanjaard L., Stefanelli P., Taha M.K., and Tzanakaki G. Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrob. Agents Chemother 47 (2003) 3430-3434